We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lung Progenitor Cells Enable Culture of 3D Organoids for Studies

By LabMedica International staff writers
Posted on 15 Mar 2018
Image: Mouse (left) and human (right) alveolar progenitor cells grow into large lung organoids in culture, and make multiple types of epithelial cells including gas exchange type 1 cells (red) and surfactant-producing type 2 cells (green) (Photo courtesy of the Morrisey Laboratory, University of Pennsylvania).
Image: Mouse (left) and human (right) alveolar progenitor cells grow into large lung organoids in culture, and make multiple types of epithelial cells including gas exchange type 1 cells (red) and surfactant-producing type 2 cells (green) (Photo courtesy of the Morrisey Laboratory, University of Pennsylvania).
An in vitro system for growth of three-dimensional lung organoids was used to characterize a line of alveolar stem cells that plays a critical role in repairing lung tissues damaged by severe influenza or other respiratory ailments such as chronic obstructive pulmonary disease (COPD).

Functional tissue regeneration is required for the restoration of normal organ function after severe injury. Some organs, such as the intestine, harbor active stem cells throughout homeostasis and regeneration; more quiescent organs, such as the lung, often contain facultative progenitor cells that are recruited after injury to participate in regeneration.

To better understand the processes involved in lung tissue regeneration, investigators at the University of Pennsylvania (Philadelphia, USA) examined the epithelial cells that line the surfaces of lung gas-exchange alveoli for stem cell behavior that could restore normal respiratory function after severe injury.

The investigators reported in the February 28, 2018, online edition of the journal Nature that they had identified an alveolar epithelial progenitor (AEP) lineage, which was embedded in a larger population of epithelial cells called alveolar type 2 cells (AT2s). AEPs were shown to be a stable lineage during alveolar homeostasis but expanded rapidly to regenerate a large proportion of the alveolar epithelium after acute lung injury. AEPs exhibited a distinct transcriptome, epigenome, and functional phenotype and responded specifically to Wnt and fibroblast growth factor (FGF) signaling.

Human AEPs could be selectively isolated by targeting the conserved cell surface marker TM4SF1. Once isolated, these cells were used as functional human alveolar epithelial progenitor cells for growing three-dimensional lung organoids.

"From our organoid culture system, we were able to show that AEPs are an evolutionarily conserved alveolar progenitor that represents a new target for human lung regeneration strategies," said senior author Dr. Edward E. Morrisey, professor of cell and developmental biology at the University of Pennsylvania. "One of the most important places to better understand lung regeneration is in the alveoli, the tiny niches within the lung where oxygen is taken up by the blood and carbon dioxide is exhaled. To better understand these delicate structures, we have been mapping the different types of cells within the alveoli. Understanding cell-cell interactions should help us discover new players and molecular pathways to target for future therapies."

Related Links:
University of Pennsylvania

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
Electrolyte Analyzer
BKE-B

Channels

Clinical Chemistry

view channel
Image: A simple oral swab detected blood-matched inflammatory signals in children with primary ciliary dyskinesia, offering a needle-free way to monitor inflammation during routine care (Image credit: Shutterstock)

Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more

Molecular Diagnostics

view channel
Image: Following FDA clearance, providers can prescribe the kit, enabling labs to process home-collected urine specimens on cobas automated platforms (Photo courtesy of Orasure Technologies)

At-Home Urine Collection Kit Enables High-Throughput STI Screening

Sexually transmitted infection screening often hinges on access to private, convenient sample collection and timely laboratory processing. Many patients face logistical or privacy barriers that limit participation... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
ADLM